BSECompany Update1d ago · 21 Jul 2026, 01:49 pm

Pls find enclosed Revised Investor Call Intimation

Ajanta Pharma Ltd · 532331

✦ AI SummaryResults

Ajanta Pharma Ltd has announced a revised timing for its earnings conference call scheduled to be held on July 30, 2026, after the board meeting. The call will now take place at 4:15 p.m. IST, and the company will release its Q1 FY 2027 unaudited financial results on the same day at 4:15 p.m. IST.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Ajanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Attachments (1)

📄

d5639c55-6b31-4c84-bbfe-4062986ee629.pdf

pdf

Download →
View document text
Ajanta Pharma Limited Ajanta Tower, 54-A, M V Road, T +91 22 6060 9000 Chakala, Andheri (E), E legal.info@ajantapharma.com Mumbai – 400 093, India W www.ajantapharma.com 21st July 2026 BSE Limited National Stock Exchange of India, Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor, Plot No. C/1, Dalal Street, G block, Bandra Kurla Complex, Mumbai - 400 001 Bandra (East), Mumbai - 400 051 Scrip Code: BSE – AJANTPHARM 532331 Scrip Code: NSE AJANTPHARM EQ Sub: Earnings Conference Call Dear Sir / Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the timing of the Earnings Conference Call scheduled to be held on Thursday, 30th July, 2026, post the Board Meeting, has been revised from 4:30 p.m. (IST) to 4:15 p.m. (IST). Please find enclosed the revised Earnings Conference Call intimation. This is for your information and records please. Yours Faithfully, Gaurang Shah Sr. VP – Legal & Company Secretary Encl.: a/a Page 1 of 2 Corporate Identity Number - L24230MH1979PLC022059 Ajanta Pharma Limited Ajanta Tower, 54-A, M V Road, T +91 22 6060 9000 Chakala, Andheri (E), E legal.info@ajantapharma.com Mumbai – 400 093, India W www.ajantapharma.com Announcement Ajanta Pharma to release Q1 FY 2027 Unaudited Financial Results on 30th July, 2026 16:15 hrs. – EARNINGS CONFERENCE CALL The Company will host an Earnings Conference Call at 16:15 hrs. IST (18:45 hrs. SST/HKT, 11:45 hrs. BST, 06:45 hrs. US ET), during which the leadership team will discuss the financial performance and take questions. A transcript of the conference call will be available at www.ajantapharma.com. Earnings Conference Call Dial-in Information Date and Time July 30, 2026 at 16:15 – 17:15 hrs IST 18:45 – 19:45 hrs SST/HKT 11:45 – 12:45 hrs BST 06:45 – 07:45 hrs US ET Dial-in Numbers Diamond pass link for faster access Click here to register Universal Access Primary Access: (+91 22 6280 1542) (+91 22 7115 8372) International Toll Free USA: 18667462133 UK: 08081011573 Hong Kong: 800964448 Singapore: 8001012045 For convenience and faster connectivity to the conference, kindly follow the below steps: 1. Register through the Diamond pass link. 2. You will receive a calendar invite along with a passcode and a PIN number. The passcode and PIN will be activated 30 minutes prior to the conference scheduled time. 3. Dial the ‘conference Dial-in number’ you will receive on your email. 4. On system prompt dial the PASSCODE followed by # key. 5. On system prompt enter the PIN followed by # key. 6. If the line gets disconnected, you need to dial the ‘conference dial-in number’ again and follow the necessary steps. Playback of Earnings Conference Call audio: Playback of the earnings call will be available 120 minutes after the end of the call on our website (www.ajantapharma.com). Contact: Investor Relations Rajeev Agarwal Abhineet Kumar E-Mail: rajeev.agarwal@ajantapharma.com E-Mail: abhineet.kumar@ajantapharma.com Page 2 of 2 Corporate Identity Number - L24230MH1979PLC022059